Oncovet Clinical Research (O.C.R.) is an innovative Contract Research Organization specialized in the conception and management of clinical trials on Dogs & Cats models with naturally occurring pathologies for efficacy assessment of drug candidates for Human Health.
O.C.R. innovative offer is at the forefront of ethics of research involving animals since Dogs & Cats included in clinical trials benefit from new therapies developed for Human.
O.C.R. main therapeutic fields are Oncology, Inflammation, Cardiology & Neurology.
O.C.R. proposes to support Pharma & Biotech in furthering their drug development programs (in preclinical & clinical phases) by getting key additional scientific information in high level predictive models of human diseases (Dogs & Cats).
O.C.R. specificity is to combine recognized experts in veterinary medicine, a multicenter recruitment network, a state of the art technical platform (histopathology lab. & advanced imaging devices) and high quality standards, applied to drug development for Human Health.
PETS AS NEW PREDICTIVE
MODELS OF HUMAN DISEASES :
Classical in vivo models have obvious translational limitations. Natural diseases in dogs and cats share numerous features with human diseases.
Why using dogs and cats models? To establish a continuum between species in terms of pharmacology, pharmacokinetics and toxicology in order to reach clinical trials in humans with more reliability.
OCR is specialized in the desing and the monitoring of Pilot & Pivotal Clinical Studies of Dogs/Cats suffering from Cancer or others Chronic Diseases.
OCR acts as a full-Vet Contract Research Organization with know-how on every step of the clinical development of a product for Pets Market (Design, Monitoring, Regulatory, Datamanagement), along with a European Network of Clinical Investigational Centers (FR, BEL, GER, NL, NOR, SWE, IT, POR, SPA, SLO, POL).
In-vitro/Ex-vivo assessment of drug candidates on cancerous dogs tissues (cell lines, primary cells, organoids, cryopreserved canine tumors)
OCR provides to our Biotech-Pharma-Academic clients a unique platform of experimental Irradiation (high and low energy) for a large spectrum of experimental animal (Pigs, Sheep, Rabbits, Mice and Rats), combined with imaging facilities (CT-scan, Scintigraphy).
Regulatory consulting in the Vet space (Pets)
Regulatory advice to support product development strategy targeting dogs and cats (drug, medical device, diagnostic test, nutraceuticals, care product)
OCR has not received any reviews.
OCR has not received any endorsements.